UNSPSC 51282932: Norfloxacin

This classification denotes a quinolone antibiotic with the molecular formula C16H18FN3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N0F8P22L1P, chemically known as 1,4-dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid but generally known as norfloxacin, which bears US NIH Compound Identifier 4539. European Medicines Agency schedules Norfloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09365MIG. The term NORFLOXACIN is an International Non-Proprietary Name.

UNSPSC 51282932 Norfloxacin, a Commodity code, shows minimal alignment with recent state and local procurement activity. The code nominally covers norfloxacin, a fluoroquinolone antibiotic, but the two recent opportunities in the database are tagged to this code without procuring norfloxacin itself. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets—both different antibiotics—with a total award value of $2,999,999.11 over a 12-month initial term plus two renewal options. Seminole County, Florida released an IFB for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, a procurement focused on opioid overdose response and drug disposal, unrelated to antibiotic supply. The mismatch between the code's nominal product scope and the actual content of tagged opportunities suggests the code captures pharmaceutical procurement broadly rather than norfloxacin-specific buys.

State and local pharmaceutical procurement under this code appears to be driven primarily by health departments and county health agencies using cooperative purchasing vehicles and traditional competitive bidding. Geographic activity centers on Illinois (state health department) and Florida (county level), though the small sample size and scope misalignment limit confidence in a broader pattern. Absent substantive recent norfloxacin-specific solicitations, pursue this code only if your firm supplies generalist pharmaceutical distribution or has existing relationships with state health departments and county cooperative purchasing consortia; the code itself does not signal active norfloxacin demand in current state and local procurement.